Skip to main content
. 2017 Mar 31;8(32):52571–52583. doi: 10.18632/oncotarget.16732

Figure 3. Characterization of ERO1A, OSBPL3 and IFI44L protein expression in human PDAC tissues and paired adjacent non-tumor tissues by immunohistochemistry staining and classified as strong expression (++), moderate expression (+), weak positive or negative expression (± or -).

Figure 3

Original magnification: 200×.